Latest News

1 min read

The president of Uganda Yoweri Kaguta Museveni has given new directives to have educational institutions reopened after four months of Covid-19 lockdown characterized by uncertainty...

5 min read

4 years have gone by since Seyi Kolade last gave in to her addiction. She walks by, a strong smile on her face, and just haunting...

WhatsApp launches test of in-app business directory feature for first time
2 min read

Facebook's messaging service WhatsApp on Wednesday launched a new feature to make it possible to search for businesses within its app for the first time, the company...

2 min read

Over 200 students are set to miss out on the 17th graduation slated for next week after the High Court in Kampala cleared Kyambogo University...

2 min read

The Speaker of parliament Jacob Oulanyah has guided that all business that had been shelved from the 10th parliament under former Speaker Rebecca Kadaga is...

1 min read

Police in Jinja has detained a 41-year-old man for allegedly defiling his seven-year-old daughter. According to police, the suspect is a resident of Butagaya Village, Butagaya...

2 min read

Kenya will next year start manufacturing Covid-19 vaccines locally in collaboration with unnamed pharmaceutical firms in a move aimed at easing supply hitches that have...

2 min read

Butambala member of parliament under the National unity platform ticket, Muwanga Kivumbi has said NUP will never be part of the Interparty Organisation for Dialogue...

3 min read

The DNA test done by police has confirmed the body retrieved from the septic at the home of Francis Onebe in Munyonyo belongs to his...

3 min read

The Bank of Uganda (BoU) has finally withdrawn a Supreme Court appeal that was contesting the Court of Appeal’s dismissal of the case it filed...

September 18, 2021

Sinovac launches clinical trial of COVID-19 vaccine on children, teenagers

 Chinese pharmaceutical company Sinovac Biotech on Friday launched the Phase III clinical trial of its COVID-19 vaccine on a group of children and teenagers between six months and 17 years old in South Africa.

The study, carried out in collaboration with South African company Numolux Group, has enrolled approximately 2,000 participants in the country, who will receive two doses of Sinovac’s CoronaVac vaccine or a placebo, 28 days apart. The efficacy assessment will be based on relevant indicators.

Numolux CEO Hilton Klein said that there are roughly 24 million children and teenagers in South Africa and that if the vaccine made by Sinovac is approved for use on them, it will help the country reach herd immunity more quickly.

The South African Health Products Regulatory Authority authorized the use of the CoronaVac vaccine on the country’s adults in July.

Views: 249